These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32682325)

  • 1. Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.
    Allain F; Delignat-Lavaud B; Beaudoin MP; Jacquemet V; Robinson TE; Trudeau LE; Samaha AN
    Neuropsychopharmacology; 2021 Jan; 46(2):305-315. PubMed ID: 32682325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent access cocaine self-administration produces psychomotor sensitization: effects of withdrawal, sex and cross-sensitization.
    Carr CC; Ferrario CR; Robinson TE
    Psychopharmacology (Berl); 2020 Jun; 237(6):1795-1812. PubMed ID: 32206828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.
    Calipari ES; Ferris MJ; Zimmer BA; Roberts DC; Jones SR
    Neuropsychopharmacology; 2013 Nov; 38(12):2385-92. PubMed ID: 23719505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-amphetamine maintenance therapy reduces cocaine use in female rats.
    Ndiaye NA; Allain F; Samaha AN
    Psychopharmacology (Berl); 2022 Dec; 239(12):3755-3770. PubMed ID: 36357743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incentive and dopamine sensitization produced by intermittent but not long access cocaine self-administration.
    Kawa AB; Valenta AC; Kennedy RT; Robinson TE
    Eur J Neurosci; 2019 Aug; 50(4):2663-2682. PubMed ID: 30968487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.
    Ferris MJ; Mateo Y; Roberts DC; Jones SR
    Biol Psychiatry; 2011 Feb; 69(3):201-7. PubMed ID: 20801429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting long-access versus short-access cocaine self-administration in rats: intermittent intake promotes addiction symptoms independent of session length.
    Allain F; Samaha AN
    Addict Biol; 2019 Jul; 24(4):641-651. PubMed ID: 29920865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.
    Siciliano CA; Saha K; Calipari ES; Fordahl SC; Chen R; Khoshbouei H; Jones SR
    J Neurosci; 2018 Jan; 38(2):484-497. PubMed ID: 29175958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.
    Calipari ES; Ferris MJ; Siciliano CA; Zimmer BA; Jones SR
    J Pharmacol Exp Ther; 2014 May; 349(2):192-8. PubMed ID: 24566123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in incentive-sensitization produced by intermittent access cocaine self-administration.
    Kawa AB; Robinson TE
    Psychopharmacology (Berl); 2019 Feb; 236(2):625-639. PubMed ID: 30368583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior.
    Kawa AB; Bentzley BS; Robinson TE
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3587-602. PubMed ID: 27481050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in cocaine self-administration behaviour under long access versus intermittent access conditions.
    Algallal H; Allain F; Ndiaye NA; Samaha AN
    Addict Biol; 2020 Sep; 25(5):e12809. PubMed ID: 31373148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking.
    Calipari ES; Siciliano CA; Zimmer BA; Jones SR
    Neuropsychopharmacology; 2015 Feb; 40(3):728-35. PubMed ID: 25212486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
    Siciliano CA; Fordahl SC; Jones SR
    J Neurosci; 2016 Jul; 36(30):7807-16. PubMed ID: 27466327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.
    Calipari ES; Jones SR
    Neuropharmacology; 2014 Jul; 82():1-10. PubMed ID: 24632529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of striatal dopamine dynamics by cocaine self-administration and amphetamine treatment in female rats.
    Siciliano CA; Mauterer MI; Fordahl SC; Jones SR
    Eur J Neurosci; 2019 Aug; 50(4):2740-2749. PubMed ID: 31111573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.
    Brodnik ZD; Xu W; Batra A; Lewandowski SI; Ruiz CM; Mortensen OV; Kortagere S; Mahler SV; España RA
    J Neurosci; 2020 Nov; 40(45):8767-8779. PubMed ID: 33046544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking Rapid and Intermittent Cocaine Infusions Enhances Both Incentive Motivation for the Drug and Cocaine-induced Gene Regulation in Corticostriatal Regions.
    Minogianis EA; Samaha AN
    Neuroscience; 2020 Aug; 442():314-328. PubMed ID: 32682656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression.
    Simmons DL; Mandt BH; Ng CM; Richards TL; Yamamoto DJ; Zahniser NR; Allen RM
    Neuropharmacology; 2013 Dec; 75():347-55. PubMed ID: 23973314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent cocaine self-administration has sex-specific effects on addiction-like behaviors in rats.
    Bender BN; Torregrossa MM
    Neuropharmacology; 2023 Jun; 230():109490. PubMed ID: 36889433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.